AKRO
Akero Therapeutics
AKRO
AKRO
Delisted
AKRO was delisted on the 8th of December, 2025.
262 hedge funds and large institutions have $4.34B invested in Akero Therapeutics in 2025 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 74 increasing their positions, 91 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $4.92B → $4.34B (-$574M)
19% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 91
31% less funds holding in top 10
Funds holding in top 10: 16 → 11 (-5)
Holders
262
Holding in Top 10
11
Calls
$52.4M
Puts
$16.3M
Top Buyers
| 1 | +$50.3M | |
| 2 | +$45.5M | |
| 3 | +$40M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$31.8M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$31.5M |
Top Sellers
| 1 | -$86.8M | |
| 2 | -$80.4M | |
| 3 | -$49.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$33.2M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$23.5M |
